NOVAST Laboratories, Limited (SHE:301569)
China · Delayed Price · Currency is CNY 18.22
+0.44 (2.47%)
Oct 30, 2026, 3:04 PM CST
NOVAST Laboratories Market Cap
NOVAST Laboratories has a market cap or net worth of 16.24 billion as of October 30, 2026. It is the 5,736th most valuable company in the world and the 934th biggest in China.
Market Cap
16.24B
Enterprise Value
14.83B
Revenue
1.01B
Global Rank
Country Rank
#934 China
PE Ratio
44.52
ChartMarket Cap Chart
Since October 15, 2026, NOVAST Laboratories's market cap has decreased from 31.31B to 16.24B, a decrease of -48.12%. That is a compound annual growth rate of -100.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 16.24B | 2.47% |
| Oct 29, 2026 | 15.85B | -6.32% |
| Oct 28, 2026 | 16.92B | 5.80% |
| Oct 27, 2026 | 16.00B | -5.03% |
| Oct 26, 2026 | 16.84B | 2.55% |
| Oct 23, 2026 | 16.42B | 5.26% |
| Oct 22, 2026 | 15.60B | -12.76% |
| Oct 21, 2026 | 17.89B | -9.19% |
| Oct 20, 2026 | 19.70B | 0.09% |
| Oct 19, 2026 | 19.68B | -12.32% |
| Oct 16, 2026 | 22.44B | -28.33% |
| Oct 15, 2026 | 31.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi AppTec | 426.39B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 319.39B |
| Shenzhen Mindray Bio-Medical Electronics | 220.24B |
| Sichuan Biokin Pharmaceutical | 101.45B |
| Betta Pharmaceuticals | 16.98B |
| Winner Medical | 16.62B |
| Double Medical Technology | 16.22B |
| Yili Chuanning Biotechnology | 16.14B |